Apotheca BiosciencesCBDC
13F holders, Q2 2026 (June 30)1holders
$0.00avg. 13F price*
At the end of Q2 2026, 1 institutions reported holding Apotheca Biosciences Inc. (CBDC) in their 13F filings. The largest holder was Vermillion Wealth Management, Inc. ($0).
- Company
- Apotheca Biosciences Inc.
- Filed as
- APTOHECA BIOSCIENCES XXXREGISTRATION REVOKED BY THE SEC EFF: 09/17/21 (Q2 2026)
- CUSIP
- 03836L107
- Latest filing quarter
- Q2 2026
Total Exit/New Position Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Vermillion Wealth Management, Inc. | 0.00% | New | 8,000 | $0 |
"% of holder's portfolio" is CBDC's weight in each manager's 13F, not the share of Apotheca Biosciences Inc. the manager owns.